VERTEX PHARMACEUTICALSVERTEX PHARMACEUTICALSVERTEX PHARMACEUTICALS

VERTEX PHARMACEUTICALS

No trades
See on Supercharts

1VRTX fundamentals

VERTEX PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of 1VRTX for the last quarter is 2.46 B EUR, and it's 1.23% lower compared to the previous quarter. The net income of Q2 24 is -3.35 B EUR.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth